QAM
REGN icon

QCI Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

QCI Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-29,539
Closed -$18.4M – 141
2020
Q2 		$18.4M Buy
29,539
+4
+0% +$2.27K 1.44% 34
2020
Q1 		$14.4M Sell
29,535
-20,715
-41% -$8.54M 1.41% 36
2019
Q4 		$18.9M Sell
50,250
-2,981
-6% -$1M 1.63% 30
2019
Q3 		$14.8M Buy
53,231
+3,581
+7% +$1.06M 1.33% 39
2019
Q2 		$15.5M Buy
49,650
+4,131
+9% +$1.38M 1.48% 36
2019
Q1 		$18.7M Buy
45,519
+3,791
+9% +$1.56M 1.84% 22
2018
Q4 		$15.6M Buy
41,728
+397
+1% +$145K 1.71% 23
2018
Q3 		$16.7M Buy
41,331
+595
+1% +$226K 1.58% 28
2018
Q2 		$14.1M Buy
40,736
+1,116
+3% +$349K 1.41% 40
2018
Q1 		$13.6M Buy
+39,620
New +$13.8M 1.45% 41
2017
Q2 		– Sell
-20
Closed -$8K – 677
2017
Q1 		$8K Buy
+20
New +$7.41K ﹤0.01% 413

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QCI Asset Management's REGN Position: Q3 2020 in Review

QCI Asset Management sold out of Regeneron Pharmaceuticals (REGN) in Q3 2020, closing a stake of 29,539 shares — an estimated $18.4M sold.

QCI Asset Management first reported a position in REGN in Q1 2017 and held it in 11 quarters. The position peaked at $18.9M in Q4 2019. 907 funds tracked by Wall St. Rank hold REGN as of Q3 2020.

  • QCI Asset Management reported no remaining Regeneron Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • QCI Asset Management sold 29,539 Regeneron Pharmaceuticals shares in Q3 2020, an estimated $18.4M.
  • QCI Asset Management first reported a position in Regeneron Pharmaceuticals in Q1 2017 and held it in 11 quarters.
  • QCI Asset Management's Regeneron Pharmaceuticals position peaked at $18.9M in Q4 2019.
  • 907 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2020.

Based on QCI Asset Management's 13F filing for Q3 2020, filed 16 Oct 2020.